Also on this list

SnagRx
$69 semaglutide and $119 tirzepatide "locked in for life," but every payment is final.
Another provider on our tirzepatide provider ranking.
Read the SnagRx review →Provider review
Edessa lists tirzepatide at $239/mo and semaglutide at $179/mo. Prices checked October 2026.
A no-questions-asked guarantee, and five months of questions in its terms.
The homepage promises a refund if you do not see results. The contract requires five months of enrollment, proof that you lost nothing, and keeps a quarter of the money.
Transparency scorecard
2 of 4 disclosed openly
What Edessa discloses about itself, read from its own pages — not estimated.
Pharmacy category stated
Not disclosed
States no federal regulatory category (503A/503B) for its pharmacy on its own site.
State coverage published
Disclosed
Publishes which states it actually serves.
A real price is published
Disclosed
A real dollar figure is published on its own site, not estimated.
No hidden commitment trap
Not disclosed
The advertised price requires a prepay, auto-refill, or other commitment we found and named.
This review's stake, stated plainly — some of the outbound links on this site are affiliate links; start a program through one and we may earn a commission at no extra cost to you. A commission does not change what a review says. Full disclosure here.
At a glance
Visit EdessaPharmacy
Not categorized
Labs
Not mentioned as a requirement, a cost or a cadence.
States
All 50 states
Also on this list

SnagRx
$69 semaglutide and $119 tirzepatide "locked in for life," but every payment is final.
Another provider on our tirzepatide provider ranking.
Read the SnagRx review →| Compound | Advertised | What you pay monthly | Pharmacy | Checked |
|---|---|---|---|---|
| Tirzepatide | $239/mo | $239/mo | Not disclosed | October 2026 |
| Semaglutide | $179/mo injection, $229 oral | $179/mo | Not disclosed | October 2026 |
What this price covers
Medication
Included
Provider visits
Included
Shipping
Not confirmed
Lab work
Not confirmed
Coaching
Not confirmed
The catch — The advertised figure is the six-month plan, and its FAQ goes a step further than a headline normally does: "The Edessa Semaglutide program is as low as $135 for your first month with no contract... Refills are as low as $135 per month." Read plainly, that says the renewal rate is $135. The renewal rate for anyone not on a six-month plan is $179, forty-four dollars more, and the same sentence shape is repeated on the tablet and tirzepatide pages with their own six-month figures.
See plans at EdessaPrices read from Edessa's own site
What they advertise
"Start for just $135 + free shipping" in the hero, "Starting at $135" on the injection card, "Starting at $199" on the tablet and "Starting at $209" on tirzepatide.
What you actually pay
$179 a month for the compounded semaglutide injection, $229 for the tablet and $239 for tirzepatide, buying one month at a time. Each product page prints all three lengths: for the injection, $179 for one month, $160 for three and $135 for six; for the tablet, $229, $209 and $199; for tirzepatide, $239, $219 and $209.
Money you will meet later
Edessa sells a compounded GLP-1 injection from $179 a month, a dissolvable GLP-1 tablet from $229 and compounded tirzepatide from $239, in all fifty states and the District of Columbia, with clinical care through OpenLoop Health. Its product pages print all three plan lengths side by side, which is more than most here do. Three things a buyer should know first. The $135 it advertises everywhere is the six-month plan, and its own FAQ calls that figure a refill rate. Two of its three products are sold as "GLP-1 Injections" and "GLP-1 Tablets", with semaglutide named only in the list under the plan table. And its money-back guarantee, advertised as no questions asked, is defined in its terms as five months of treatment, a demonstration that you lost no weight, and a refund with twenty-five percent withheld.
Edessa appears on our tirzepatide provider ranking, our semaglutide provider ranking and our combined weight loss injections ranking.
Tap any compound to read our plain-English guide — what the evidence shows, how it is dosed, and what it costs elsewhere.
Edessa states no 503A/503B category for the pharmacy that fills your prescription.
Not named, and "USA certified" is not a designation anyone issues. Its footer says only that it is "partnered with multiple USA certified pharmacies" and that its team meets with them regularly about shortages, delays and medication testing — a description of a relationship rather than an identification. Neither 503A nor 503B appears anywhere. The clinical network is named: OpenLoop Health, whose clinicians are stated to retain the prescribing decision. The company, Edessa Group, LLC, publishes an address in Las Vegas, a phone number, and terms with Nevada courts as the venue that cap its total liability at one hundred dollars.
A 503A pharmacy compounds for one named patient; a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Compounded peptides are not FDA-approved.
All fifty and the District of Columbia, per its terms — and qualified in the same breath: "Some services may not be available in all 50 states or Washington D.C. Subject to change." No exclusions are named.
The part they would rather you skipped
Edessa's guarantee, as advertised, is: "If you don't see results, we'll refund your purchase no questions asked." Its own terms define a different offer. There, you are eligible for a refund "if you can demonstrate that you have not lost weight after following our weight loss program for a minimum of 5 months" — so five months of paid enrollment first, at $895 on the six-month injection plan, and the burden of demonstrating an outcome sits with you. The same sentence keeps a quarter of the money: the refund is "minus dr. consult fees of 25%". "No questions asked" and "demonstrate that you have not lost weight" are not compatible claims, and they sit two clicks apart on the same site. Around it are two smaller things. The advertised $135 is the six-month plan, and the FAQ calls it a refill price, which for anyone on a monthly plan is $179. And two products are sold by class rather than by name, "GLP-1 Injections" and "GLP-1 Tablets", with semaglutide named only in a bullet list under the plan table and in the safety section. Its terms also say the final charge to your card "may fluctuate contingent upon the prescribed medication and the chosen pharmacy", on a site whose homepage says "What you see is what you pay." Above all of it runs a statistics band — eighteen percent average weight loss, nine out of ten calling it the most effective treatment to date, ninety-three percent keeping it off — footnoted, at the bottom of the page, to self-reported customer data.
Other providers on our tirzepatide provider ranking — the closest match to what Edessa sells.





166 more providers are on our tirzepatide provider ranking — see the full list. Every provider we review →
A provider comparison is half the decision. The other half is whether the compound does anything for you at all. The evidence below is where that gets settled.
Ready to get started?
Prices and plans in this category change often — check Edessa's current pricing before you decide. Ours was read from their own site.
Facts on this page reflect Edessa's own public disclosures when we last checked them. Prices and terms change without notice — confirm on Edessa's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved. See our disclosure and editorial policy.
Edessa
2 compounds from $179/mo injection, $229 oral